How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

4,427 results for

Congenital Heart Disease Imaging in Adults

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Multi-center Trial of SPECT Myocardial Blood Flow Quantitation for Detection of Coronary Artery Disease

imaging (MPI) and will receive invasive coronary angiogram are recruited to receive SPECT MBF study. Condition or disease Coronary Artery Disease Detailed Description: Patients with suspected or known coronary artery disease who are scheduled for clinically indicated SPECT myocardial perfusion imaging (MPI) and likely will further receive invasive coronary angiogram will be recruited for a SPECT MBF study. The MBF study will be performed as an adjunct to MPI utilizing the same rest and stress (...) with the study procedures Written informed consent Exclusion Criteria: History or risk of severe bradycardia History of myocardial infarction, dilated cardiomyopathy, hypertrophic cardiomyopathy, valve issue or congenital heart disease Wheezing asthma or COPD Known second- or third-degree AV block Known hypersensitivity to dipyridamole or adenosine Breastfeeding or pregnancy Claustrophobia or inability to lie still in a supine position Unwillingness or inability to provide informed consent Contacts

2018 Clinical Trials

142. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations. Full Text available with Trip Pro

on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J . 2014 ; 35 : 2541–2619 ) (20) , particularly for patients who have had acute coronary syndrome or those with cardiac stents, especially if the stent implantation or cardiac event occurred within 1 year. Assessment of Patient Bleeding (...) management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol . 2017 ; 69 : 871–898 , x 4 Raval, A.N., Cigarroa, J.E., Chung, M.K. et al. American Heart Association Clinical Pharmacology Subcommittee of the Acute Cardiac Care and General Cardiology Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Quality of Care

2019 Society of Interventional Radiology

143. ACR–ASNR–SPR Practice Parameter for the Performance of Magnetic Resonance Imaging (MRI) of the Head and Neck

, contraindications to magnetic field exposure (see section V below), artifacts from metallic objects in the head and neck, and long scan times relative to CT for emergent indications. CT may be a better option than MRI if there are patient limitations such as significant claustrophobia, altered mentation, or an underlying medical condition such as congestive heart failure or a breathing disorder that makes lying flat difficult. CT may also be the procedure of choice for evaluating neck lesions associated (...) ]. Additionally, if the brain or subarachnoid space is involved, dedicated imaging of the brain should be considered [114]. Diffusion- weighted imaging of the brain is also generally useful in this circumstance. 2. Paranasal sinuses and nasal cavity CT is the imaging modality of choice for evaluation of inflammatory disorders of the paranasal sinuses and nasal cavity, with MRI reserved for evaluating complications of inflammatory and neoplastic sinus disease [40-42], including orbital, skull base

2019 American Society of Neuroradiology

144. ACR–ASNR–SPR Practice Parameter for the Performance and Interpretation of Magnetic Resonance Imaging (MRI) of the Brain

. Vascular a. Acute ischemia and infarction [9-13]. b. Chronic vascular disease [14-16]. c. Vascular malformations such as developmental venous anomaly, cavernous angioma, arteriovenous malformation, arteriovenous fistulas and aneurysm [17-20]. d. Arterial or venous/dural venous sinus abnormalities, including congenital and acquired disorders and thrombosis [21,22]. e. Additionally, magnetic resonance angiography (MRA) may provide more detailed noninvasive vascular information. (See the ACR–ASNR–SNIS–SPR (...) collaboratively by the American College of Radiology (ACR), the American Society of Neuroradiology (ASNR), and the Society for Pediatric Radiology (SPR). Magnetic resonance imaging (MRI) of the brain is a proven and well-established imaging modality in the evaluation and assessment of normal and abnormal conditions of the brain. MRI of the brain is the most sensitive technique available because of its high sensitivity in exploiting inherent contrast differences of tissues as a result of variable magnetic

2019 American Society of Neuroradiology

145. ACR–ASNR–SPR Practice Parameter for the Performance of Intracranial Magnetic Resonance Perfusion Imaging

in pediatric patients, especially in neonates, given the theoretical advantage in SNR due to higher velocities of flow in children and because GBCA administration is not required. Special considerations in interpreting perfusion studies in infants and young children include congenital heart disease involving right to left shunts, age-related changes in flow velocity, and sickle cell anemia in which flow velocity is typically elevated. The use of rCBV has limited application in pediatric brain tumors due (...) , or advances in knowledge or technology subsequent to publication of this document. However, a practitioner who employs an approach substantially different from the guidance in this document is advised to document in the patient record information sufficient to explain the approach taken. The practice of medicine involves not only the science, but also the art of dealing with the prevention, diagnosis, alleviation, and treatment of disease. The variety and complexity of human conditions make it impossible

2019 American Society of Neuroradiology

146. ACR–ASNR Practice Parameter for the Performance of Non-Breast Magnetic Resonance Imaging (MRI) Guided Procedures

, Truwit CL. Intraoperative MR-guided neurosurgery. J Magn Reson Imaging 2008;27:368-375. 50. Lewin JS, Nour SG, Meyers ML, et al. Intraoperative MRI with a rotating, tiltable surgical table: a time use study and clinical results in 122 patients. AJR 2007;189:1096-1103. 51. Razavi R, Hill DL, Keevil SF, et al. Cardiac catheterisation guided by MRI in children and adults with congenital heart disease. Lancet 2003;362:1877-1882. 52. Nazarian S, Kolandaivelu A, Zviman MM, et al. Feasibility of real-time (...) . 4. Catheter-based procedures Using passive or active tracking techniques, catheter and/or guidewire navigation can be performed in the cardiovascular system in near-real-time to achieve better soft tissue visualization and to obtain more pertinent physiological information compared to conventional X-ray fluoroscopic techniques. Preliminary clinical data demonstrate the safety and feasibility of MRI guidance for diagnostic cardiac catheterization in patients with congenital heart disease

2019 American Society of Neuroradiology

147. Vascular imaging

Specialty Health. All Rights Reserved. 8 ? Diagnosis – testing based on a reasonable suspicion of a particular condition or disorder, usually due to the presence of signs or symptoms ? Management – testing to direct therapy of an established condition, which may include preoperative or postoperative imaging, or imaging performed to evaluate the response to nonsurgical intervention ? Surveillance – periodic assessment following completion of therapy, or for monitoring known disease that is stable (...) – intracranial 14 Vertebrobasilar aneurysm or dissection 15 Vertebrobasilar stenosis or occlusion 15 Chest 15 Vascular Imaging Copyright © 2019. AIM Specialty Health. All Rights Reserved. 3 Aortic aneurysm or dissection 15 Atheromatous disease (Adult only) 16 Pulmonary embolism 16 Other vascular indications – chest 18 Abdomen and Pelvis 18 Aneurysm of the abdominal aorta 18 Aneurysm of the iliac vessels 19 Arteriovenous malformation or fistula 20 Dissection of the abdominal aorta or branch vessel 20 Hematoma

2019 AIM Specialty Health

148. Chest imaging

embolism 15 Sarcoidosis 15 Pleural Conditions 15 Bronchopleural fistula (Adult only) 15 Pleural fluid collection 15 Pneumothorax, unexplained or recurrent 15 Chest Wall and Diaphragmatic Conditions 16 Imaging of the Chest Copyright © 2019. AIM Specialty Health. All Rights Reserved. 3 Breast implant rupture 16 Diaphragmatic hernia 16 Pectoralis muscle tear 16 Thoracic outlet syndrome 16 Signs and Symptoms 16 Cough (chronic or persistent) 16 Fever of unknown origin 17 Hemoptysis 17 Hoarseness, dysphonia (...) imaging includes the area between the lung apices and the costophrenic sulci—specifically, the lung parenchyma, pleura, mediastinum, and musculoskeletal structures of the thorax. Chest imaging studies are not appropriate for cardiac and coronary artery imaging. For imaging of the heart, see the AIM guidelines for the specific CPT code being requested. Vascular imaging of the thorax is addressed in the Vascular Imaging guidelines. In the majority of clinical situations, chest radiographs should have

2019 AIM Specialty Health

149. Oncologic imaging

Health. All Rights Reserved. 3 Pancreatic Cancer 72 Paraneoplastic Syndrome 74 Penile, Vaginal, and Vulvar Cancers 75 Prostate Cancer 77 Sarcoma of Bone and Soft Tissue 80 Thoracic Cancers – Pleura, Thymus, Heart and Mediastinum 83 Thyroid Cancer 85 Uterine Cancer 88 Codes 91 History 93 Oncologic Imaging Copyright © 2019. AIM Specialty Health. All Rights Reserved. 4 Description and Application of the Guidelines The AIM Clinical Appropriateness Guidelines (hereinafter “the AIM Clinical Appropriateness (...) laboratory studies, prior imaging and supplementary testing) to identify suspected or established diseases or conditions. ? For suspected diseases or conditions: o Based on the clinical evaluation, there is a reasonable likelihood of disease prior to imaging; and o Current literature and standards of medical practice support that the requested imaging study is the most appropriate method of narrowing the differential diagnosis generated through the clinical evaluation and can be reasonably expected

2019 AIM Specialty Health

150. Appropriate Use Criteria: Imaging of the Brain

sclerosis and other white matter diseases 11 Inflammatory conditions, unspecified 11 Trauma 11 Trauma 11 Tumor or Neoplasm 12 Acoustic neuroma (Adult only) 12 Pituitary adenoma (Adult only) 13 Tumor – not otherwise specified 13 Miscellaneous Conditions 14 Bell’s palsy (peripheral facial nerve palsy) 14 Cerebrovascular accident or transient ischemic attack 14 Dementia (Adult only) 15 Horner’s syndrome 16 Hydrocephalus/ventricular assessment 16 Mental status change and encephalopathy 17 Movement disorders (...) , diagnoses, or imaging modalities not specifically addressed are considered not medically necessary. It is recognized that imaging often detects abnormalities unrelated to the condition being evaluated. Such findings must be considered within the context of the clinical situation when determining whether additional imaging is required. Congenital and Developmental Conditions Ataxia, congenital or hereditary Includes ataxia-telangiectasia, fragile X syndrome, and congenital anomalies of the posterior

2019 AIM Specialty Health

151. Heart failure

, fluid retention, and fatigue; and signs including basal crepitations, and peripheral oedema. Heart failure is (...) classified into two main categories with either a reduced or preserved ejection fraction. Symptoms are classified according to severity using the New York Heart Association (NYHA) functional classification. The most common underlying cause is coronary artery disease. Complications include arrhythmias, depression, cachexia, chronic kidney disease, sexual dysfunction, and sudden cardiac (...) Factors for HF ( Hypertension , Diabetes Mellitus, Metabolic Syndrome, and Atherosclerotic Disease) e249 5. Cardiac Structural Abnormalities 2013 8. Evaluation and Management of Right-Sided Heart Failure : A Scientific Statement From the American Heart Association Evaluation and Management of Right-Sided Heart Failure : A Scientific Statement From the American Heart Association | Circulation Search for this keyword Search Search for this keyword Search Header Publisher Menu AHA Scientific Statement

2018 Trip Latest and Greatest

152. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

10, 2014:-–- 2014 AHA/ACC Valvular Heart Disease Guideline: Executive Summary 5 PGL 5.2.0 DTD JAC19929_proof 22 April 2014 10:01 pm included representatives from the following ACC com- mittees and councils: Adult Congenital and Pediatric Cardiology Section, Association of International Gover- nors, Council on Clinical Practice, Cardiovascular Section Leadership Council, Geriatric Cardiology Section Lead- ership Council, Heart Failure and Transplant Council, Interventional Council, Lifelong (...) ). The present document applies to adult patients with VHD. Management of patients with congenital heart disease (CHD) and infants and children with valve disease are not addressed here. The document recommends a combination of lifestyle modi?cations and medications that constitute GDMT. Both for GDMT and other rec- ommended drug treatment regimens, the reader is advised to con?rm dosages with product insert material and to carefully evaluate for contraindications and drug–drug

2014 Society for Cardiovascular Angiography and Interventions

153. Valvular Heart Disease: Guidelines For the Management of Patients With

have been proposed, based on current natural history studies of patients with VHD. The present document applies to adult patients with VHD. Management of patients with congenital heart disease and infants and children with valve disease are not addressedhere.Thedocumentrecommendsacombination of lifestyle modi?cations and medications that constitute GDMT. Both for GDMT and other recommended drug treatment regimens, the reader is advised to con?rm dos- ages with product insert material (...) for the Management of Adults With Congenital Heart Disease ACC/AHA 2008 (7) Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice EAE/ASE 2009 (8) Recommendations for Evaluation of Prosthetic Valves With Echocardiography and Doppler Ultrasound ASE 2009 (9) Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy ACCF/AHA 2011 (10) Guidelines on the Management of Cardiovascular Diseases During Pregnancy ESC 2011 (11) Antithrombotic and Thrombolytic Therapy

2014 American College of Cardiology

154. Diagnosis and Treatment of Fetal Cardiac Disease Full Text available with Trip Pro

on Jump to Free Access article Diagnosis and Treatment of Fetal Cardiac Disease A Scientific Statement From the American Heart Association , MD , MD , MD , MD , MD , MD , MD , MD , MD , MD , DO , MD , MD , RN , MD, DSc, FAHA , MD, FAHA , MD , and MD MDon behalf of the American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council on Cardiovascular Disease in the Young and Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and Council (...) on Cardiovascular and Stroke Nursing Mary T. Donofrio , Anita J. Moon-Grady , Lisa K. Hornberger , Joshua A. Copel , Mark S. Sklansky , Alfred Abuhamad , Bettina F. Cuneo , James C. Huhta , Richard A. Jonas , Anita Krishnan , Stephanie Lacey , Wesley Lee , Erik C. MichelfelderSr , Gwen R. Rempel , Norman H. Silverman , Thomas L. Spray , Janette F. Strasburger , Wayne Tworetzky , and Jack Rychik and on behalf of the American Heart Association Adults With Congenital Heart Disease Joint Committee of the Council

2014 American Heart Association

155. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

the following ACC committees and councils: Adult Congenital and Pediatric Cardiology Section, Association of International Gover- nors, Council on Clinical Practice, Cardiovascular Section Leadership Council, Geriatric Cardiology Section Lead- ership Council, Heart Failure and Transplant Council, Interventional Council, Lifelong Learning Oversight Committee, Prevention of Cardiovascular Disease Com- mittee, and Surgeon Council). Reviewers’ RWI informa- tion was distributed to the writing committee (...) , 2) medical therapy, and 3) intervention. The purpose of these sub- sections was to categorize the COR according to the clinical decision-making pathways that caregivers use in the management of patients with VHD. New recom- mendations for assessment of the severity of valve lesions have been proposed, based on current natural history studies of patients with VHD. The present document applies to adult patients with VHD. Management of patients with congenital heart disease and infants and children

2014 Society for Cardiovascular Angiography and Interventions

156. Management of Heart Failure (4th Edition)

underlying causes of HF in adults are: ? Coronary artery disease (CAD) ? Hypertension ? Dilated cardiomyopathy-idiopathic, familial ? Valvular heart disease ? Diabetic cardiomyopathy Other causes of HF include: ? Congenital heart disease ? Cor pulmonale ? Pericardial disease: constrictive pericarditis, cardiac tamponade ? Hypertrophic cardiomyopathy ? Viral myocarditis ? Acute rheumatic fever 5. AETIOLOGY ? Toxic: Alcohol, cardiotoxic chemotherapy e.g. doxorubicin, trastuzumab (Herceptin (...) are: ? Coronary artery disease (CAD) ? Hypertension ? Dilated cardiomyopathy-idiopathic, familial ? Valvular heart disease ? Diabetic cardiomyopathy Other causes of HF include: ? Congenital heart disease ? Cor pulmonale ? Pericardial disease: constrictive pericarditis, cardiac tamponade ? Hypertrophic cardiomyopathy ? Viral myocarditis ? Acute rheumatic fever ? Toxic: Alcohol, cardiotoxic chemotherapy e.g. doxorubicin, trastuzumab (Herceptin), cyclophosphamide. ? Endocrine and metabolic disorders: thyroid

2019 Ministry of Health, Malaysia

157. 2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints D Full Text available with Trip Pro

on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Cardiac Imaging). Circulation . 2009 ; 119:154–86. International Society for Nomenclature of Paediatric and Congenital Heart Disease. International Paediatric and Congenital Cardiac Code. Available at: . Accessed October 25, 2018. Lang RM, Badano LP, Mor-Avi V, et al. . Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European (...) in heterogeneous nomenclature and definitions across the spectrum of congenital heart diseases. In an effort to bridge these frequently competing classification systems, the International Society for Nomenclature of Pediatric and Congenital Heart Disease developed the International Pediatric and Congenital Cardiac Code ( ), a comprehensive list of congenital cardiovascular malformations that contains >1 000 diagnostic terms related to pediatric and congenital cardiac disease and cross-maps the terms from

2019 American Heart Association

158. Museum of TMH Multimodality Imaging Center: Congenital aplasia of the left iliac vein in a patient with concomittant sturge-weber syndrome and may-thurner syndrome with congenital aberrant left femoral to right greater saphenous vein bypass Full Text available with Trip Pro

syndrome and May-Thurner syndrome with congenital aberrant left femoral to right greater saphenous vein bypass. 49 Cheema Zulfiqar F ZF Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas, USA. Lumsden Alan B AB eng Case Reports Journal Article United States Methodist Debakey Cardiovasc J 101508600 1947-6108 IM Abnormalities, Multiple Adult Angiography, Digital Subtraction Endovascular Procedures instrumentation Femoral Vein abnormalities diagnostic imaging Humans Iliac (...) Museum of TMH Multimodality Imaging Center: Congenital aplasia of the left iliac vein in a patient with concomittant sturge-weber syndrome and may-thurner syndrome with congenital aberrant left femoral to right greater saphenous vein bypass 22891112 2012 12 27 2016 11 25 1947-6108 8 1 2012 Jan Methodist DeBakey cardiovascular journal Methodist Debakey Cardiovasc J Museum of TMH Multimodality Imaging Center. Congenital aplasia of the left iliac vein in a patient with concomittant Sturge-Weber

2012 Methodist DeBakey cardiovascular journal

159. ACR/SIR/SPR Practice Parameter for Specifications and Performance of Image-Guided Percutaneous Drainage/Aspiration of Abscesses and Fluid Collections (PDAFC)

, and treatment of disease. The variety and complexity of human conditions make it impossible to always reach the most appropriate diagnosis or to predict with certainty a particular response to treatment. Therefore, it should be recognized that adherence to the guidance in this document will not assure an accurate diagnosis or a successful outcome. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources, and the needs (...) of the benefits, alternatives, and risks of the procedures. The physician must have a thorough understanding of imaging anatomy (including congenital and developmental variants), the imaging equipment to be used during the procedures, radiation safety considerations, and physiologic monitoring equipment. The physician must also have access to adequate supplies and personnel to perform the procedure safely. PDAFC procedures must be performed by a physician who has the following qualifications. The physician’s

2018 Society of Interventional Radiology

160. Optimal Use of Ionizing Radiation in Cardiovascular Imaging

with regard to childhood and teenage radiation exposure that tissue weighting factors do not take into account the increased sensitivity of the tissue of the pediatric population. Thus, for children and adolescents, a given radiation exposure confers a greater risk than the same exposure would confer to an adult population. In addition, children who do not have life threatening disorders have a long life expectancy, which provides a longer period for radiation-induced illness to present (13). 4.2 (...) Optimal Use of Ionizing Radiation in Cardiovascular Imaging EXPERT CONSENSUS DOCUMENT 2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts Writing Committee Members John W. Hirshfeld, JR, MD, FACC, FSCAI, Chair Victor A. Ferrari, MD, FACC, Co

2018 American College of Cardiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>